{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:42:02Z","timestamp":1791481322299,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41375-025-02744-x","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:22:33Z","timestamp":1756722153000},"page":"2686-2696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-5354","authenticated-orcid":false,"given":"Ana","family":"Alfonso-Pierola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-4091","authenticated-orcid":false,"given":"David","family":"Martinez-Cuadr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-8540","authenticated-orcid":false,"given":"Rebeca","family":"Rodr\u00edguez-Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-140X","authenticated-orcid":false,"given":"Pilar","family":"Mart\u00ednez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-513X","authenticated-orcid":false,"given":"Teresa","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1866-8831","authenticated-orcid":false,"given":"M\u00f3nica A.","family":"Romero-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Serrano-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-1208","authenticated-orcid":false,"given":"Juan M.","family":"Bergua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimundo","family":"Garc\u00eda-Boyero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-1649","authenticated-orcid":false,"given":"Mar","family":"Tormo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia L.","family":"Sossa-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"P\u00e9rez-Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodr\u00edguez-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda F.","family":"Bass-Maturana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"L\u00f3pez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-824X","authenticated-orcid":false,"given":"Lorenzo","family":"Algarra-Algarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5049-3673","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Vidriales-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"P\u00e9rez-Encinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7578-2030","authenticated-orcid":false,"given":"Manuel","family":"Barrios-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Sayas-Lloris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Capurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Olave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cuervo-Lozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Lavilla-Rubira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Mena-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Valero-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Casado-Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Balerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Stevenazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Labrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Le\u00f3n-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"de Rueda-Ciller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Arce-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Amigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Raposo-Puglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Boluda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-5593","authenticated-orcid":false,"given":"Pau","family":"Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PETHEMA Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"de Rueda-Ciller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"2744_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373:1136\u201352.","journal-title":"N Engl J Med"},{"key":"2744_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"2744_CR3","unstructured":"Recomendaciones para el tratamiento de primera l\u00ednea adaptado al riesgo de la leucemia mielobl\u00e1stica aguda en pacientes candidatos a quimioterapia intensiva. https:\/\/www.fundacionpethema.es\/sites\/default\/files\/protocolos\/Recomendaciones%20PETHEMA%20LMA-FLOW_bis_1_10_22_V2.pdf (accessed 5 Dec2024)."},{"key":"2744_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.annonc.2020.02.018","volume":"31","author":"M Heuser","year":"2020","unstructured":"Heuser M, Ofran Y, Boissel N, Brunet Mauri S, Craddock C, Janssen J, et al. Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals Oncol. 2020;31:697\u2013712.","journal-title":"Annals Oncol"},{"key":"2744_CR5","unstructured":"Acute Myeloid Leukemia - Guidelines Detail. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1411 (accessed 5 Dec2024)."},{"key":"2744_CR6","doi-asserted-by":"crossref","unstructured":"Ge S, Wang J, He Q, Zhu J, Liu P, Wang H, et al. Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML. Ann Hematol. 2024;103:3855\u201366.","DOI":"10.1007\/s00277-024-05632-z"},{"key":"2744_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"2744_CR8","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","volume":"98","author":"D Grimwade","year":"2001","unstructured":"Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood. 2001;98:1312\u201320.","journal-title":"Blood"},{"key":"2744_CR9","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","volume":"138","author":"M Heuser","year":"2021","unstructured":"Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, et al. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2021;138:2753\u201367.","journal-title":"Blood"},{"key":"2744_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1182\/bloodadvances.2020003195","volume":"5","author":"C Simoes","year":"2021","unstructured":"Simoes C, Paiva B, Mart\u00ednez-Cuadr\u00f3n D, Bergua JM, Vives S, Algarra L, et al. Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial. Blood Adv. 2021;5:760\u201370.","journal-title":"Blood Adv"},{"key":"2744_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.clml.2012.07.004","volume":"12","author":"K Usuki","year":"2012","unstructured":"Usuki K, Kurosawa S, Uchida N, Yakushiji K, Waki F, Matsuishi E, et al. Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission. Clin Lymphoma Myeloma Leuk. 2012;12:444\u201351.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2744_CR12","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199812033392301","volume":"339","author":"PA Cassileth","year":"1998","unstructured":"Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med. 1998;339:1649\u201356.","journal-title":"N Engl J Med"},{"key":"2744_CR13","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1182\/blood-2011-07-370247","volume":"118","author":"E Vellenga","year":"2011","unstructured":"Vellenga E, Van Putten W, Ossenkoppele GJ, Verdonck LF, Theobald M, Cornelissen JJ, et al. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood. 2011;118:6037\u201342.","journal-title":"Blood"},{"key":"2744_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/10428190701223309","volume":"48","author":"ST Kim","year":"2007","unstructured":"Kim ST, Jung CW, Lee J, Kwon JM, Oh SY, Park BB, et al. Postremission therapy for acute myeloid leukemia in the first remission. Leuk Lymphoma. 2007;48:937\u201343.","journal-title":"Leuk Lymphoma"},{"key":"2744_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4081\/hr.2020.8380","volume":"12","author":"ZA Yegin","year":"2020","unstructured":"Yegin ZA, Dikyar A, Kaynar LA, Can F, \u00d6zkurt ZN, Ya\u011fc\u0131 M. Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy. Hematol Rep. 2020;12:51\u201354.","journal-title":"Hematol Rep"},{"key":"2744_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s12185-017-2389-8","volume":"107","author":"T Miyamoto","year":"2018","unstructured":"Miyamoto T, Nagafuji K, Fujisaki T, Uchida N, Matsue K, Henzan H, et al. Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission. Int J Hematol. 2018;107:468\u201377.","journal-title":"Int J Hematol"},{"key":"2744_CR17","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.bbmt.2014.05.019","volume":"20","author":"D Capelli","year":"2014","unstructured":"Capelli D, Chiarucci M, Poloni A, Saraceni F, Mancini G, Trappolini S, et al. Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicin. Biol Blood Marrow Transpl. 2014;20:1399\u2013406.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2744_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0140-6736(97)09214-3","volume":"351","author":"AK Burnett","year":"1998","unstructured":"Burnett AK, Goldstone AH, Stevens RMF, Hann IM, Rees JKH, Gray RG, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial. Lancet. 1998;351:700\u20138.","journal-title":"Lancet"},{"key":"2744_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood.V97.1.56","volume":"97","author":"WG Woods","year":"2001","unstructured":"Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard DR, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood. 2001;97:56\u201362.","journal-title":"Blood"},{"key":"2744_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1365-2141.2005.05628.x","volume":"130","author":"DA Breems","year":"2005","unstructured":"Breems DA, L\u00f6wenberg B. Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia. Br J Haematol. 2005;130:825\u201333.","journal-title":"Br J Haematol"},{"key":"2744_CR21","first-page":"1428","volume":"334","author":"Y Ravindranath","year":"1996","unstructured":"Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncol Group N Engl J Med. 1996;334:1428\u201334.","journal-title":"Pediatric Oncol Group N Engl J Med"},{"key":"2744_CR22","first-page":"125","volume":"84","author":"J de la Rubia","year":"1999","unstructured":"de la Rubia J, Sanz GF, Mart\u00edn G, Mart\u00ednez J, Cervera J, Solves P, et al. Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong disease-free survival. Haematologica. 1999;84:125\u201332.","journal-title":"Haematologica"},{"key":"2744_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1200\/JCO.1993.11.6.1046","volume":"11","author":"S Amadori","year":"1993","unstructured":"Amadori S, Testi AM, Aric\u00f2 M, Comelli A, Giuliano M, Madon E, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group. J Clin Oncol. 1993;11:1046\u201354.","journal-title":"J Clin Oncol"},{"key":"2744_CR24","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1016\/j.clml.2018.07.290","volume":"18","author":"W Limvorapitak","year":"2018","unstructured":"Limvorapitak W, Barnett MJ, Hogge DE, Forrest DL, Nevill TJ, Narayanan S, et al. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis. Clin Lymphoma Myeloma Leuk. 2018;18:e481\u2013e491.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2744_CR25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1470-2045(14)70281-5","volume":"15","author":"RK Hills","year":"2014","unstructured":"Hills RK, Castaigne S, Appelbaum FR, Delaunay J, Petersdorf S, Othus M, et al. Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials. Lancet Oncol. 2014;15:986\u201396.","journal-title":"Lancet Oncol"},{"key":"2744_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa1614359","volume":"377","author":"RM Stone","year":"2017","unstructured":"Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, et al. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation. N Engl J Med. 2017;377:454\u201364.","journal-title":"N Engl J Med"},{"key":"2744_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41409-024-02248-9","volume":"59","author":"JR Passweg","year":"2024","unstructured":"Passweg JR, Baldomero H, Ciceri F, de la C\u00e1mara R, Glass B, Greco R, et al. Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone Marrow Transpl. 2024;59:803\u201312.","journal-title":"Bone Marrow Transpl"},{"key":"2744_CR28","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1056\/NEJM199812033392309","volume":"339","author":"AK Burnett","year":"1998","unstructured":"Burnett AK. Transplantation in first remission of acute myeloid leukemia. N Engl J Med. 1998;339:1698\u20131700.","journal-title":"N Engl J Med"},{"key":"2744_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.leukres.2016.12.001","volume":"53","author":"AD Heini","year":"2017","unstructured":"Heini AD, Berger MD, Seipel K, Taleghani BM, Baerlocher GM, Leibundgut K, et al. Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years. Leuk Res. 2017;53:28\u201334.","journal-title":"Leuk Res"},{"key":"2744_CR30","doi-asserted-by":"crossref","unstructured":"Ye W, Wu X, Zhao R, Jin X, Li H, Qu Y, et al. Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis. Stem Cell Res Ther. 2024;15:153.","DOI":"10.1186\/s13287-024-03766-5"},{"key":"2744_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000495206","volume":"141","author":"Z Li","year":"2019","unstructured":"Li Z, Liu Y, Wang Q, Chen L, Ma L, Hao S. Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis. Acta Haematol. 2019;141:164\u201375.","journal-title":"Acta Haematol"},{"key":"2744_CR32","doi-asserted-by":"crossref","unstructured":"Sargas C, Ayala R, Larr\u00e1yoz MJ, Chill\u00f3n MC, Rodriguez-Arboli E, Bilbao C, et al. Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood Cancer J. 2023;13:77.","DOI":"10.1038\/s41408-023-00835-5"},{"key":"2744_CR33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41409-023-02070-9","volume":"58","author":"J Chen","year":"2023","unstructured":"Chen J, Labopin M, Pabst T, Zhang X, Jiang E, Tucci A, et al. Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT. Bone Marrow Transpl. 2023;58:1322\u201330.","journal-title":"Bone Marrow Transpl"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02744-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:34:49Z","timestamp":1762331689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02744-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02744-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}